Suscríbete a nuestras actualizaciones (en inglés) aquí para estar al tanto de los últimos avances y actualizaciones en materia de propiedad intelectual.
Explore how major biotech and pharmaceutical jurisdictions approach double patenting and divisional applications, and discover strategies for building stronger global patent portfolios.
A recent UPC decision highlights the risks of delaying an opt out. Learn why early action may be essential to keep European patents outside UPC jurisdiction.
Boult is pleased to announce that it has been ranked as “Outstanding” for non-contentious patent matters by the World Intellectual Property Review (WIPR) for 2026.
Boult is proud to be recognised in Lexology Index: IP 2026, with Dr Catherine Wolfe named a Global Elite Thought Leader and multiple partners ranked across the prestigious report.
EPO patent filings show strong growth in materials, food technology, coatings and surface technologies, highlighting innovation driven by sustainability and advanced manufacturing.
Discover the key patent portfolio questions investors ask during IP due diligence and how chemistry and materials companies can strengthen investor confidence and support fundraising success.
New UK IPO guidance following the Emotional Perception AI ruling brings greater clarity to patent examination, aligning UK practice with the EPO and impacting AI, software and quantum computing invent
Discover how Tyruko compares with Tysabri, including biosimilar approval, manufacturing and formulation differences, patent considerations and the investigation into reported adverse patient outcomes.
Eminem has suffered a setback in his Australian dispute with Swim Shady. The ruling highlights why trade mark owners must file strategically and retain evidence of genuine use.
From 1 August 2026, Jersey becomes an independent Madrid System designation. Brand owners must separately designate Jersey for new filings, renewals and subsequent designations.
From 9 July 2026, Algeria's accession to the Hague Apostille Convention will simplify document attestation for IP matters between member countries, replacing multi-stage legalisation with Apostille.
Swatch's US$170m claim against Samsung could reshape UK trade mark damages by recognising the commercial value of brand reputation, exclusivity and goodwill in the digital economy.
The EASYBREATH and Elvie decisions show how technical function can limit design protection and why evidence of aesthetic design choices remains crucial.
The NHS is introducing an injectable form of Keytruda (pembrolizumab), reducing administration time to under two minutes and helping improve patient experience.
T 1043/24 aligns with the anticipated outcome of G 1/25, confirming that description amendments are needed to address inconsistencies with amended claims while allowing unclaimed embodiments to remain
From 1 July 2026, Phase II of the EU Design Reform introduces dynamic and animated representations, more design views, amendment options, and significant procedural changes.
Suscríbete a nuestras actualizaciones (en inglés) aquí para estar al tanto de los últimos avances y actualizaciones en materia de propiedad intelectual.
